• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB 2.17% 45.0¢

DIMERIX LIMITED

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DXB 12:13 133 58K
12:13 Last post  BT6487 Comments Created with Sketch.  133  Views Created with Sketch.  58K 
DXB 07/02/25 21 8.0K
07/02/25 Last post  CloseTheMarkets Comments Created with Sketch.  21  Views Created with Sketch.  8.0K 
DXB 05/02/25 0 391
05/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  391 
DXB 05/02/25 0 523
05/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  523 
DXB 04/02/25 17 6.0K
04/02/25 Last post  RYNZN Comments Created with Sketch.  17  Views Created with Sketch.  6.0K 
DXB
DXB Chart
30 31 32
04/02/25 1.9K 790K
04/02/25 Last post  RYNZN Comments Created with Sketch.  1.9K  Views Created with Sketch.  790K 
DXB 03/02/25 38 13K
03/02/25 Last post  frenchfries57 Comments Created with Sketch.  38  Views Created with Sketch.  13K 
DXB
US Based Manufacturer
02/02/25 0 502
02/02/25 Last post  frenchfries57 Comments Created with Sketch.  0  Views Created with Sketch.  502 

See All Discussions arrow Created with Sketch.

Timeline

Application for quotation of securities - DXB
05 Feb 14:32
 
Appendix 3Y Correction
05 Feb 08:37
 
Change of Director's Interest Notice - NW
04 Feb 14:53
 
Investor Presentation - Euroz Hartley Healthcare Forum
04 Feb 09:04
 
Application for quotation of securities - DXB
31 Jan 13:59
 
Quarterly Appendix 4C and Activities Report
28 Jan 08:33
 
View More arrow Created with Sketch.
(20min delay)
Last
45.0¢
Change
-0.010(2.17%)
Mkt cap ! $251.2M
Open High Low Value Volume
46.0¢ 46.0¢ 43.5¢ $610.2K 1.364M

Buyers (Bids)

No. Vol. Price($)
2 19728 45.0¢
 

Sellers (Offers)

Price($) Vol. No.
45.5¢ 21850 7
View Market Depth
Last trade - 14.35pm 10/02/2025 (20 minute delay) ?
Last
45.5¢
  Change
-0.010 ( 0.37 %)
Open High Low Volume
45.5¢ 45.5¢ 43.5¢ 482723
Last updated 14.53pm 10/02/2025 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.